Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...

There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart ...

A research team led by Lee Dae-in and Kang Dong-oh at Korea University Guro Hospital Cardiovascular Center and Kim Sun-won at Korea University Ansan Hospital Cardiovascular Center confirmed that even ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...

Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure: Berlin Tuesday, December 23, 2025, 14:00 Hrs [IST] Bayer announced that Japan’s Min ...

Smartwatches and wearable heart monitors can help detect issues such as irregular heart rhythms. But they also have limits and do not replace a diagnosis.

Berlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a ...

The actor James Van Der Beek, known for Dawson’s Creek, revealed at the end of 2024, when he was 47, that he’d been diagnosed ...

That’s the thinking behind the next installment of Rock Music Menu’s Holiday Gift Guide, and the first onedesigned ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA(R) home sleep apnea test.